Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Low Vitamin D Levels May Harm Heart Health

By LabMedica International staff writers
Posted on 23 Nov 2015
Vitamin D is important for bone health, promoting calcium absorption, but studies have increasingly suggested the vitamin may also play an important role in heart health, linking vitamin D deficiency to increased risk for high blood pressure, heart attack and heart disease.

Individuals who do not get enough vitamin D through dietary sources including oily fish, eggs, and supplements or sun exposure often have vitamin D deficiency as when the levels of the vitamin in the body are too low, which is determined by measuring levels of 25-hydroxyvitamin D (25-OHD) in the blood.

Scientists at the Intermountain Medical Center Heart Institute (Salt Lake City, UT, USA) assessed how vitamin D levels affected the health of more than 230,000 patients who were on their database. More...
The team allocated each patient into one of four groups dependent on their 25-OHD levels: less than 15 ng/mL, 15–29 ng/mL, 30–44 ng/mL, and more than 45 ng/mL. Over the next three years, they monitored the patients for any incidence of major cardiac events, including coronary heart disease, heart attack, stroke and heart failure, as well as incidence of kidney failure and death.

The investigators found that patients whose 25-OHD levels were less than 15 ng/mL were 35% more likely to experience a cardiovascular event in the subsequent three years than participants in the other three groups. The risk for cardiovascular events was the same for participants whose 25-OHD levels were 15–29 ng/mL, 30–44 ng/mL, or more than 45 ng/mL, according to the results. Accordingly, these findings indicate that if a person's 25-OHD levels are 15–29 ng/mL or above, they should not be concerned about the effect their vitamin D levels may have on their heart, and vitamin D supplementation is unlikely to improve heart health any further.

J. Brent Muhlestein, MD, the lead author of the study, said, “Although vitamin D levels above 30 were traditionally considered to be normal, more recently, some studies have proposed that anything above 15 was a safe level. But the numbers had not been backed up with any studies until now. Even if any level above 15 is safe, one out of 10 people still have vitamin D levels lower than that. This equates to a very large percentage of our population. The best way to determine one’s vitamin D level is by getting a blood test.” The study was presented on November 9, 2015, at the American Heart Association's Scientific Sessions held Orlando, FL, USA).

Related Links:

Intermountain Medical Center Heart Institute 



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.